From a genetics perspective, primary GBM manifests EGFR amplification, PTEN mutation, and the entire loss of chromosome 10, whereas secondary GBM shows frequent mutations in the TP53 gene (encodes tumor-suppressor protein p53) with longer overall survival (133). This evidence concerns the gene PTEN and glioblastoma.